| Dr Vishal S Oza, MD | |
|
800 W Central Rd, Arlington Heights, IL 60005-2349 | |
| (847) 618-1000 | |
| Not Available |
| Full Name | Dr Vishal S Oza |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 20 Years |
| Location | 800 W Central Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023264546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 036-121147 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Community Hospital 1 | Arlington heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Anesthesia Partners Llc | 6204737596 | 189 |
| Northwestern Medical Faculty Foundation | 4587576814 | 3255 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Twelve to 18 months seems to be the ideal length of time between giving birth and getting pregnant again, according to new research from the University of British Columbia and the Harvard T.H. Chan School of Public Health.
JoVE, the Journal of Visualized Experiments, will publish a procedure to identify newborns and children at-risk for developmental problems, especially those born prematurely.
Surgeons at the University of Illinois Hospital & Health Sciences System performed a rare living-donor parathyroid gland transplant to help a 22-year-old woman maintain normal calcium levels without the need for high-dose supplementation.
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes, and could even have implications for other autoimmune diseases.
› Verified 8 days ago
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Twelve to 18 months seems to be the ideal length of time between giving birth and getting pregnant again, according to new research from the University of British Columbia and the Harvard T.H. Chan School of Public Health.
JoVE, the Journal of Visualized Experiments, will publish a procedure to identify newborns and children at-risk for developmental problems, especially those born prematurely.
Surgeons at the University of Illinois Hospital & Health Sciences System performed a rare living-donor parathyroid gland transplant to help a 22-year-old woman maintain normal calcium levels without the need for high-dose supplementation.
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes, and could even have implications for other autoimmune diseases.
› Verified 8 days ago
| Entity Name | Midwest Anesthesia Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255380184 PECOS PAC ID: 6204737596 Enrollment ID: O20040120000034 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Twelve to 18 months seems to be the ideal length of time between giving birth and getting pregnant again, according to new research from the University of British Columbia and the Harvard T.H. Chan School of Public Health.
JoVE, the Journal of Visualized Experiments, will publish a procedure to identify newborns and children at-risk for developmental problems, especially those born prematurely.
Surgeons at the University of Illinois Hospital & Health Sciences System performed a rare living-donor parathyroid gland transplant to help a 22-year-old woman maintain normal calcium levels without the need for high-dose supplementation.
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes, and could even have implications for other autoimmune diseases.
› Verified 8 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Twelve to 18 months seems to be the ideal length of time between giving birth and getting pregnant again, according to new research from the University of British Columbia and the Harvard T.H. Chan School of Public Health.
JoVE, the Journal of Visualized Experiments, will publish a procedure to identify newborns and children at-risk for developmental problems, especially those born prematurely.
Surgeons at the University of Illinois Hospital & Health Sciences System performed a rare living-donor parathyroid gland transplant to help a 22-year-old woman maintain normal calcium levels without the need for high-dose supplementation.
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes, and could even have implications for other autoimmune diseases.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vishal S Oza, MD Po Box 88648, Chicago, IL 60680-1648 Ph: (800) 444-6110 | Dr Vishal S Oza, MD 800 W Central Rd, Arlington Heights, IL 60005-2349 Ph: (847) 618-1000 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Twelve to 18 months seems to be the ideal length of time between giving birth and getting pregnant again, according to new research from the University of British Columbia and the Harvard T.H. Chan School of Public Health.
JoVE, the Journal of Visualized Experiments, will publish a procedure to identify newborns and children at-risk for developmental problems, especially those born prematurely.
Surgeons at the University of Illinois Hospital & Health Sciences System performed a rare living-donor parathyroid gland transplant to help a 22-year-old woman maintain normal calcium levels without the need for high-dose supplementation.
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes, and could even have implications for other autoimmune diseases.
› Verified 8 days ago
Neil Patel, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 880 W Central Rd Fl 2, Arlington Heights, IL 60005 Phone: 847-618-4400 Fax: 847-618-4409 | |
Dr. Santosh Kumar Singh, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd, Suite 3600, Arlington Heights, IL 60005 Phone: 847-255-8084 | |
Dr. Paul Marsiglia, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2101 S Arlington Heights Rd, Suite 165, Arlington Heights, IL 60005 Phone: 847-593-6800 Fax: 847-593-6803 | |
Phillip Williams, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1100 W Central Rd, Arlington Heights, IL 60005 Phone: 847-259-5408 | |
Dr. Kirsten Johanna Lee, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-255-8662 | |
Tomasz W Przezdziak, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-1000 |